"Unpacking Anti-Obesity Medications: Insights from Jeffrey D. Glover and Benjamin F. Chavis"

FDA-approved weight loss medications offer hope for millions battling obesity. However, a surge in counterfeit drugs poses significant risks, especially in vulnerable communities. Law enforcement must combat this illegal trade, while proposed CMS rules could enhance access to authentic treatments, ultimately safeguarding public health and diminishing counterfeit demand.